Insight Molecular Diagnostics IMDX
NASDAQ IMDX
$3.52 +0.14 (+4.14%)
As of: Sep 30, 2026 · 3:34 PM EDT

Insight Molecular Diagnostics (IMDX) Revenue (2020 - 2026)

Updated

Insight Molecular Diagnostics (IMDX) posted Revenue of $239,000 for Q2 2026, down 53.9% from $518,000 a year earlier but up 646.9% from the prior quarter.

Analysis

Insight Molecular Diagnostics (IMDX) Revenue (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Revenue at Insight Molecular Diagnostics was $1.67 million, down 60.8% year-over-year; for FY2025, it was $4.06 million, up 115.6% from FY2024.

  • Annual Revenue has increased for three consecutive years, with a five-year compound annual growth rate of 27.2% (FY2020 to FY2025).
  • In prior years, Insight Molecular Diagnostics' Revenue was $1.88 million in FY2024 (+25.1%), $1.5 million in FY2023 (+56.9%), $958,000 in FY2022 (-56.4%) and $2.2 million in FY2021 (+80.8%).
  • Quarterly Revenue has run from a low of $32,000 in Q1 2026 to a high of $3.59 million in Q4 2021 over five years.
  • On a year-over-year basis, Revenue has declined in each of the last three quarters, with growth averaging 92.6% over the last seven quarters.
  • The strongest year-over-year quarter for Revenue in the past five years was Q4 2021, with growth of 613.5%; the weakest was Q1 2026, with a decline of 98.5%.
  • According to Business Quant data, Revenue for the three prior quarters was $32,000 (Q1 2026), $1.14 million (Q4 2025) and $260,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn 11.99 Bn
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn 12.59 Bn
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn 6.27 Bn
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn 2.89 Bn
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn 9.76 Bn
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn 6.59 Bn
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn 5.44 Bn
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn 1.74 Bn
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn 4.98 Bn
10 Insight Molecular Diagnostics 110.27 Mn 33.98 Mn 157,000.00 239,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 239,000.00
Mar 31, 2026 32,000.00
Dec 31, 2025 1.14 Mn
Sep 30, 2025 260,000.00
Jun 30, 2025 518,000.00
Mar 31, 2025 2.14 Mn
Dec 31, 2024 1.49 Mn
Sep 30, 2024 115,000.00
Jun 30, 2024 104,000.00
Mar 31, 2024 176,000.00
Dec 31, 2023 314,000.00
Sep 30, 2023 429,000.00
Jun 30, 2023 463,000.00
Mar 31, 2023 297,000.00
Dec 31, 2022 274,000.00
Sep 30, 2022 67,000.00
Jun 30, 2022 237,000.00
Mar 31, 2022 380,000.00
Dec 31, 2021 3.59 Mn
Sep 30, 2021 984,000.00
API Access

Insight Molecular Diagnostics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=IMDX&period=max&api_key=YOUR_API_KEY